Visible light-activated prodrug system with a novel heavy-atom-free photosensitizer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Visible light-activated prodrug system with a novel heavy-atom-free photosensitizer

Published:2023-07 Issue: Volume:91 Page:129365
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Yang Shudan,Wang Lushun^ORCID,Loredo Axel^ORCID,Wang Shichao^ORCID,Ada Nischal,Xiao Han^ORCID

Funder

National Institutes of Health

U.S. Department of Defense

Welch Foundation

Cancer Prevention and Research Institute of Texas

John S. Dunn Foundation

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference24 articles.

1. Regulatory perspectives of Type II prodrug development and time-dependent toxicity management: Nonclinical Pharm/Tox analysis and the role of comparative toxicology;Wu;Toxicology,2007

2. The expanding role of prodrugs in contemporary drug design and development;Rautio;Nat Rev Drug Discov,2018

3. A New Classification of Prodrugs: Regulatory Perspectives;Wu;Pharmaceuticals.,2009

4. NIR light-triggered nanomaterials-based prodrug activation towards cancer therapy. WIREs Nanomedicine;Zhang;NanoBiotechnology,2020

5. Light activation uncaged;Evanko;Nat Methods,2007

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Precision in Photodynamic Therapy: Innovations in Light-Driven and Bioorthogonal Activation;Pharmaceutics;2024-03-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP